Over 150 million people around the world have at least 1 potentially life-threatening asthma attack in a year.
Early warning signs for decline are so poorly recognised that 45% of people who passed away due to asthma died before even reaching hospital.
This is because there are no reliable and effective solutions to pick up these signs. This problem also extends to respiratory and pharmaceutical research, making clinical trials less robust and highly inefficient.
At Albus Health, we are building a monitoring system for objective clinical research as well as truly personalised asthma care at home.
Existing Solutions are ineffective
Requires patients to change behaviour
Awards and Competitions
Clinical Study in progress with
Contract awarded to deploy Albus device in a clinical study for one of the largest global pharmaceutical companies.
At Albus Health, we believe that no-one should be hospitalised for
asthma, let alone die from it.